Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic strategy for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to meal intake, https://wisesocialsmedia.com/story5933116/unveiling-the-therapeutic-potential-of-glp-1-peptides